Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/1997
10/30/1997CA2252508A1 Substrates and inhibitors of proteolytic enzymes
10/30/1997CA2252458A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
10/30/1997CA2251680A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
10/29/1997EP0803511A1 Allergenic proteins from ragweed and uses therefor
10/29/1997EP0672063B1 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
10/29/1997CN1163271A Process for preparing peptide derivative
10/28/1997US5681928 Acylation, alkylation of an aminoglycine; insertion into peptide
10/28/1997US5681926 Thrombin receptor binding peptides
10/28/1997US5681925 Trifunctional antithrombin and antiplatelet peptides
10/28/1997US5681813 Thiodepsipeptide isolated from a marine actinomycete
10/28/1997US5681541 (oligo or poly)peptides
10/23/1997WO1997039029A2 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
10/23/1997WO1997039026A1 Novel peptides and nootropic agent
10/23/1997WO1997039025A1 A cyclic hepta-peptide derivative from colonial ascidians, lissoclinum sp.
10/23/1997WO1997039024A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/23/1997WO1997039023A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects
10/23/1997WO1997038703A1 Chimeric isoprenoid synthases and uses thereof
10/23/1997WO1997038571A1 Compositions and methods for taxol biosynthesis
10/23/1997WO1997031657A3 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors
10/23/1997CA2252099A1 A cyclic hepta-peptide derivative from colonial ascidians, lissoclinum sp.
10/23/1997CA2251904A1 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
10/23/1997CA2251797A1 Novel peptides and nootropic agent
10/23/1997CA2250707A1 Cysteine-containing or methionine-containing peptides with immunomodulatory effects
10/23/1997CA2219151A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/22/1997EP0801686A1 Process for preparing cyclosporin a
10/22/1997EP0801655A1 Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
10/22/1997EP0698041B1 Synthetic aglucodalbaheptide antibiotics
10/22/1997EP0693122A4 Glutamylcysteine synthetase light subunit
10/21/1997US5679782 Inhibit receptor binding activity of urokinase-type plasminogen activator
10/21/1997US5679642 Peptide-chelator conjugates
10/21/1997US5679641 Peptides of human P53 protein for use in human T cell response inducing compositions, and human P53 protein-specific cytotoxic t-lymphocytes
10/21/1997US5679640 Immunosuppressant peptides
10/21/1997US5679531 Methods of detecting βA4 peptide species ending at carboxy-terminus residue 42 using monoclonal antibody 369.2B
10/21/1997US5679530 Immunogenic complex of isolated polypeptides of specific amino acid sequence to a keyhole lampet hemocyanin
10/21/1997US5679355 Vaccines containing non-ionic surfactant vesicles
10/21/1997US5679352 Synthetic Haemophilus influenzae conjugate vaccine
10/16/1997WO1997038127A1 Interaction trap systems for detecting protein interactions
10/16/1997WO1997038013A1 Modulation of mammalian telomerase by peptide nucleic acids
10/16/1997WO1997038010A2 Fusogenic liposomes
10/16/1997WO1997038009A1 Cyclic adhesion inhibitors
10/16/1997WO1997030975A3 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support
10/15/1997EP0801074A1 Isolation of peptides from green barley leaf extract and use of same to inhibit human platelet aggregation
10/15/1997EP0800535A1 Fibronectin adhesion inhibitors
10/15/1997EP0800529A1 Peptides and synthetic cell membranes
10/15/1997CN1162318A New peptide active substance and production thereof
10/14/1997US5677423 Process for performing retro-aldol reaction
10/14/1997US5677420 Phospholipase c-inhibiting peptides
10/14/1997US5677419 Cyclic vasoactive peptide analogs
10/14/1997US5677198 Assay for peptide metabolites from the amino-terminal telopeptide domain of type I collagen
10/14/1997US5677195 Forming oligonucleotides or peptides by forming flow channels in substrate surface, each of flow channels comprising walls which form fluid-tight seals with surface and a flow intake and outlet, flowing nucleic acids through channels to bind
10/14/1997US5677184 Genetic engineered chinese hamster ovary cells
10/13/1997CA2178132A1 Isolation of novel peptides from green barley leaf extract and use of same to inhibit human platelet aggregation
10/10/1997CA2190812A1 Polypeptide
10/09/1997WO1997037223A1 Identification and isolation of novel polypeptides having ww domains and methods of using same
10/09/1997WO1997037030A1 Method of screening dna-binding protein, plasmid to be used therefor, and dna-binding protein
10/09/1997WO1997037005A1 Method for preventing hiv-1 infection of cd4+ cells
10/09/1997WO1997036922A1 Inhibitor and stimulator of stem cell proliferation and uses thereof
10/09/1997WO1997036921A1 Antifungal peptides from scleroderma texense
10/09/1997WO1997031941A3 Soluble tachykinin antagonists, the preparation and use thereof
10/09/1997DE19613933A1 Cyclische Adhäsionsinhibitoren Cyclic adhesion inhibitors
10/09/1997CA2250866A1 Identification and isolation of novel polypeptides having ww domains and methods of using same
10/09/1997CA2250829A1 Method for preventing hiv-1 infection of cd4+ cells
10/09/1997CA2249716A1 Inhibitor and stimulator of stem cell proliferation and uses thereof
10/08/1997EP0799241A1 Peptides having immunomodulatory activity
10/08/1997EP0777679A4 Delivery of nucleic acids
10/08/1997EP0482089B1 Method of treating autoimmune uveoretinitis in human
10/08/1997CN1161745A Peptides marked with metal chelates
10/08/1997CN1161698A Cyclic hexapeptide somatostatin analogues
10/07/1997US5674976 Coupling first modular component to third modular component to yield precyclized gamma turn mimetic, cyclizing
10/07/1997US5674850 High purity desmopressin produced in large single batches
10/07/1997US5674840 Synthetic aglucodalbaheptide antibiotics
10/07/1997US5674712 Recombinant vector and use thereof for exocellular preparation of antibodies in single molecule form from Bacillus subtilis
10/07/1997US5674710 Recombinant techniques for production of human brain natriuretic peptide
10/07/1997US5674676 HCV peptide antigens and method of determining HCV
10/02/1997WO1997035981A1 Insect neuropeptides genes and peptides
10/02/1997WO1997035969A2 Peptide ligands of the urokinase receptor
10/02/1997WO1997035962A1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator
10/02/1997WO1997035877A1 Antibiotic peptides from bovine milk
10/02/1997WO1997027276A3 Nucleic acids encoding polypeptides having absidia lipase activity
10/02/1997WO1997024111A3 Novel hyaluronic acid receptors binding agents and the use thereof
10/02/1997DE19612805A1 Antifungische Peptide aus Scleroderma texense Texense antifungal peptides from Scleroderma
10/02/1997CA2250128A1 Insect neuropeptides genes and peptides
10/01/1997EP0797997A2 Use of bradykinin antagonists for the preparation of medicaments
10/01/1997EP0797590A1 Neurotrophic peptides of activity dependent neurotrophic factor
10/01/1997EP0797584A1 Cooperative combinations of ligands contained within a matrix
10/01/1997EP0797447A1 Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
10/01/1997CN1036010C Preparation and application of memory enhancing peptide (MEP)
09/1997
09/30/1997US5672681 Conformationally restricted mimetics of gamma turns and peptides containing the same
09/30/1997US5672659 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
09/30/1997US5672585 Method and composition for treating thrombosis
09/30/1997US5672584 Modified with end groups
09/30/1997US5672581 Drug delivery; aerosol, programmed, portable, disposable
09/30/1997US5672488 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
09/27/1997CA2200040A1 Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders
09/25/1997WO1997035199A1 Azatide peptidomimetics
09/25/1997WO1997035197A1 PURIFICATION OF TISSUE PLASMINOGEN ACTIVATOR (tPA)
09/25/1997WO1997035196A1 Engineering affinity ligands for macromolecules
09/25/1997WO1997035193A1 Cryptic peptides and method for their identification
09/25/1997WO1997034924A1 Process and intermediates for the synthesis of lhrh antagonists
09/25/1997WO1997034923A1 Process and intermediates for the synthesis of lhrh antagonists